Targretin (Valeant Pharmaceuticals North America LLC)


Welcome to the PulseAid listing for the Targretin drug offered from Valeant Pharmaceuticals North America LLC. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Valeant Pharmaceuticals North America LLC
NON-PROPRIETARY NAME: bexarotene
SUBSTANCE NAME: BEXAROTENE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Retinoid [EPC],Retinoids [Chemical/Ingredient]
ROUTE: TOPICAL
DOSAGE FORM: GEL
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2000-06-28
END MARKETING DATE: 0000-00-00


Targretin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTargretin from Valeant Pharmaceuticals North America LLC
LABELER NAME: Valeant Pharmaceuticals North America LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/100g)
START MARKETING DATE: 2000-06-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0187-5525_ad234f26-3b95-40ce-9698-250e846b3880
PRODUCT NDC: 0187-5525
APPLICATION NUMBER: NDA021056

Other BEXAROTENE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Mylan Institutional Inc.Bexarotene
Mylan Pharmaceuticals Inc.Bexarotene
Oceanside Pharmaceuticalsbexarotene
Valeant Pharmaceuticals North America LLCTargretin